{"id":8499,"date":"2026-11-09T13:00:52","date_gmt":"2026-11-09T03:30:52","guid":{"rendered":"https:\/\/hepatitissa.asn.au\/communitynews\/?p=8499"},"modified":"2026-11-10T14:16:51","modified_gmt":"2026-11-10T04:46:51","slug":"fattyliver101","status":"publish","type":"post","link":"https:\/\/hepatitissa.asn.au\/communitynews\/2026\/11\/fattyliver101\/","title":{"rendered":"Fatty Liver (or MASLD) 101"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Fatty&nbsp;liver disease, the lay term for Metabolic Dysfunction-Associated Steatotic Liver<em> <\/em>Disease (MASLD), is a common condition that affects one in three people in Australia.<sup data-fn=\"049158b5-7417-459c-913a-6b294d04e8d6\" class=\"fn\"><a href=\"#049158b5-7417-459c-913a-6b294d04e8d6\" id=\"049158b5-7417-459c-913a-6b294d04e8d6-link\">1<\/a><\/sup> It was previously referred to as Non-Alcoholic Fatty Liver Disease (NAFLD).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In some people, the build-up of fat in the liver leads to inflammation and liver damage which can progress to liver disease and liver cancer. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Early detection is the key to preventing these outcomes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Having hepatitis C increases the risk of developing fatty liver disease.<sup data-fn=\"ffa16ecb-062e-4da8-a126-fd0d4502d0f4\" class=\"fn\"><a href=\"#ffa16ecb-062e-4da8-a126-fd0d4502d0f4\" id=\"ffa16ecb-062e-4da8-a126-fd0d4502d0f4-link\">2<\/a><\/sup> Unfortunately, curing hepatitis C doesn\u2019t cure fatty liver disease and people can remain at risk of liver damage after hepatitis C treatment.<sup data-fn=\"99809ed9-e883-4dce-a21d-59d0d4d0e873\" class=\"fn\"><a href=\"#99809ed9-e883-4dce-a21d-59d0d4d0e873\" id=\"99809ed9-e883-4dce-a21d-59d0d4d0e873-link\">3<\/a><\/sup><\/p>\n\n\n\n<figure class=\"wp-block-pullquote\"><blockquote><p>People who have hepatitis B and fatty liver disease have a significantly higher risk of liver damage<\/p><\/blockquote><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Hepatitis B doesn\u2019t increase the risk of fatty liver disease but because fatty liver is so common it\u2019s thought that as many as 60 per cent of people with hepatitis B also have the condition.<sup data-fn=\"cea6ac2b-559a-4187-8d27-1b3e38eeebbe\" class=\"fn\"><a href=\"#cea6ac2b-559a-4187-8d27-1b3e38eeebbe\" id=\"cea6ac2b-559a-4187-8d27-1b3e38eeebbe-link\">4<\/a><\/sup><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">People who have hepatitis B and fatty liver disease have a significantly higher risk of liver damage, even when their hepatitis B is being treated.<sup data-fn=\"cea6ac2b-559a-4187-8d27-1b3e38eeebbe\" class=\"fn\"><a href=\"#cea6ac2b-559a-4187-8d27-1b3e38eeebbe\" id=\"cea6ac2b-559a-4187-8d27-1b3e38eeebbe-link\">4<\/a><\/sup><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">People who are overweight\/obese or have metabolic disorders (diabetes, high cholesterol) are very likely to have fatty liver disease and should be screened for it.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This is particularly important if they also have viral hepatitis.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Fatty liver disease is mostly treated with diet and exercise and some helpful resources are included with this alert. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A good starting point for people who need to manage the condition is <em>The Fatty Liver Diet<\/em> from the Liver Foundation which includes a 12 week program of emails to help people make changes to their diet and activity levels.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Hepatitis SA Library has<a href=\"https:\/\/hepatitissa.asn.au\/communitynews\/2026\/11\/library-fattyliver\/\"> a good collection of resources on fatty liver<\/a> which you can browse <a href=\"https:\/\/hepatitissa.asn.au\/communitynews\/2026\/11\/library-fattyliver\/\">here<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n<ol class=\"wp-block-footnotes\"><li id=\"049158b5-7417-459c-913a-6b294d04e8d6\">\u201cFatty Liver.\u201d Healthdirect Australia, 2025. <a href=\"https:\/\/www.healthdirect.gov.au\/fatty-liver\">https:\/\/www.healthdirect.gov.au\/fatty-liver<\/a>. <a href=\"#049158b5-7417-459c-913a-6b294d04e8d6-link\" aria-label=\"Jump to footnote reference 1\">\u21a9\ufe0e<\/a><\/li><li id=\"ffa16ecb-062e-4da8-a126-fd0d4502d0f4\">Non-Alcoholic Fatty Liver Disease and Hepatitis: is there a link?\u201d HealthCentral, 2024. <a href=\"https:\/\/www.healthcentral.com\/article\/hepatitis-c-and-fatty-liver-disease\">https:\/\/www.healthcentral.com\/article\/hepatitis-c-and-fatty-liver-disease<\/a>.  <a href=\"#ffa16ecb-062e-4da8-a126-fd0d4502d0f4-link\" aria-label=\"Jump to footnote reference 2\">\u21a9\ufe0e<\/a><\/li><li id=\"99809ed9-e883-4dce-a21d-59d0d4d0e873\">Noureddin, Mazen, Micaela M. Wong, Tsuyoshi Todo, et al \u201cFatty Liver in Hepatitis C Patients Post-Sustained Virological Response with Direct-Acting Antivirals.\u201d World Journal of Gastroenterology 24, no. 11 (2018): 1269\u201377. <a href=\"https:\/\/doi.org\/10.3748\/wjg.v24.i11.1269\">https:\/\/doi.org\/10.3748\/wjg.v24.i11.1269<\/a>. <a href=\"#99809ed9-e883-4dce-a21d-59d0d4d0e873-link\" aria-label=\"Jump to footnote reference 3\">\u21a9\ufe0e<\/a><\/li><li id=\"cea6ac2b-559a-4187-8d27-1b3e38eeebbe\">\u201cLiver Fat Affects the Prognosis for Chronic Hepatitis B.\u201d Research Features, November 30, 2020. <a href=\"https:\/\/researchfeatures.com\/liver-fat-affects-prognosis-chronic-hepatitis-b\/\">https:\/\/researchfeatures.com\/liver-fat-affects-prognosis-chronic-hepatitis-b\/<\/a> <a href=\"#cea6ac2b-559a-4187-8d27-1b3e38eeebbe-link\" aria-label=\"Jump to footnote reference 4\">\u21a9\ufe0e<\/a><\/li><li id=\"cea6ac2b-559a-4187-8d27-1b3e38eeebbe\">\u201cLiver Fat Affects the Prognosis for Chronic Hepatitis B.\u201d Research Features, November 30, 2020. <a href=\"https:\/\/researchfeatures.com\/liver-fat-affects-prognosis-chronic-hepatitis-b\/\">https:\/\/researchfeatures.com\/liver-fat-affects-prognosis-chronic-hepatitis-b\/<\/a> <a href=\"#cea6ac2b-559a-4187-8d27-1b3e38eeebbe-link\" aria-label=\"Jump to footnote reference 5\">\u21a9\ufe0e<\/a><\/li><\/ol>\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Fatty&nbsp;liver disease, the lay term for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), is a common condition that affects one in three people in Australia. It was previously referred to as&hellip;<\/p>\n","protected":false},"author":5,"featured_media":8505,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_FSMCFIC_featured_image_caption":"","_FSMCFIC_featured_image_nocaption":"","_FSMCFIC_featured_image_hide":"","footnotes":"[{\"content\":\"\u201cFatty Liver.\u201d Healthdirect Australia, 2025. <a href=\\\"https:\/\/www.healthdirect.gov.au\/fatty-liver\\\">https:\/\/www.healthdirect.gov.au\/fatty-liver<\/a>.\",\"id\":\"049158b5-7417-459c-913a-6b294d04e8d6\"},{\"content\":\"Non-Alcoholic Fatty Liver Disease and Hepatitis: is there a link?\u201d HealthCentral, 2024. <a href=\\\"https:\/\/www.healthcentral.com\/article\/hepatitis-c-and-fatty-liver-disease\\\">https:\/\/www.healthcentral.com\/article\/hepatitis-c-and-fatty-liver-disease<\/a>. \",\"id\":\"ffa16ecb-062e-4da8-a126-fd0d4502d0f4\"},{\"content\":\"Noureddin, Mazen, Micaela M. Wong, Tsuyoshi Todo, et al \u201cFatty Liver in Hepatitis C Patients Post-Sustained Virological Response with Direct-Acting Antivirals.\u201d World Journal of Gastroenterology 24, no. 11 (2018): 1269\u201377. <a href=\\\"https:\/\/doi.org\/10.3748\/wjg.v24.i11.1269\\\">https:\/\/doi.org\/10.3748\/wjg.v24.i11.1269<\/a>.\",\"id\":\"99809ed9-e883-4dce-a21d-59d0d4d0e873\"},{\"content\":\"\u201cLiver Fat Affects the Prognosis for Chronic Hepatitis B.\u201d Research Features, November 30, 2020. <a href=\\\"https:\/\/researchfeatures.com\/liver-fat-affects-prognosis-chronic-hepatitis-b\/\\\">https:\/\/researchfeatures.com\/liver-fat-affects-prognosis-chronic-hepatitis-b\/<\/a>\",\"id\":\"cea6ac2b-559a-4187-8d27-1b3e38eeebbe\"},{\"content\":\"\u201cLiver Fat Affects the Prognosis for Chronic Hepatitis B.\u201d Research Features, November 30, 2020. <a href=\\\"https:\/\/researchfeatures.com\/liver-fat-affects-prognosis-chronic-hepatitis-b\/\\\">https:\/\/researchfeatures.com\/liver-fat-affects-prognosis-chronic-hepatitis-b\/<\/a>\",\"id\":\"cea6ac2b-559a-4187-8d27-1b3e38eeebbe\"}]","_ppma_block_editor_authors":""},"categories":[12,13],"tags":[280,364,365],"issue":[],"ppma_author":[128],"class_list":["post-8499","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-resources","category-living-with-hepatitis","tag-masld","tag-fatty-liver","tag-nafld"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Fatty Liver (or MASLD) 101 | HepSA Community News<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hepatitissa.asn.au\/communitynews\/2026\/11\/fattyliver101\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fatty Liver (or MASLD) 101 | HepSA Community News\" \/>\n<meta property=\"og:description\" content=\"Fatty&nbsp;liver disease, the lay term for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), is a common condition that affects one in three people in Australia. It was previously referred to as&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hepatitissa.asn.au\/communitynews\/2026\/11\/fattyliver101\/\" \/>\n<meta property=\"og:site_name\" content=\"HepSA Community News\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/HepatitisSA\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-09T03:30:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-10T04:46:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2026\/11\/prill-iStock-682222256-fattyliver101-web.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Rose Magdalene\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@hep_sa\" \/>\n<meta name=\"twitter:site\" content=\"@hep_sa\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Rose Magdalene\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/2026\\\/11\\\/fattyliver101\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/2026\\\/11\\\/fattyliver101\\\/\"},\"author\":{\"name\":\"Rose Magdalene\",\"@id\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/#\\\/schema\\\/person\\\/ad926e1f11c1abf6ece6961500fe2a4e\"},\"headline\":\"Fatty Liver (or MASLD) 101\",\"datePublished\":\"2026-11-09T03:30:52+00:00\",\"dateModified\":\"2026-11-10T04:46:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/2026\\\/11\\\/fattyliver101\\\/\"},\"wordCount\":299,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/2026\\\/11\\\/fattyliver101\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/prill-iStock-682222256-fattyliver101-web.jpg\",\"keywords\":[\"MASLD\",\"fatty liver\",\"NAFLD\"],\"articleSection\":[\"Resources\",\"Living with Hepatitis\"],\"inLanguage\":\"en-AU\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/2026\\\/11\\\/fattyliver101\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/2026\\\/11\\\/fattyliver101\\\/\",\"url\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/2026\\\/11\\\/fattyliver101\\\/\",\"name\":\"Fatty Liver (or MASLD) 101 | HepSA Community News\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/2026\\\/11\\\/fattyliver101\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/2026\\\/11\\\/fattyliver101\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/prill-iStock-682222256-fattyliver101-web.jpg\",\"datePublished\":\"2026-11-09T03:30:52+00:00\",\"dateModified\":\"2026-11-10T04:46:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/2026\\\/11\\\/fattyliver101\\\/#breadcrumb\"},\"inLanguage\":\"en-AU\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/2026\\\/11\\\/fattyliver101\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-AU\",\"@id\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/2026\\\/11\\\/fattyliver101\\\/#primaryimage\",\"url\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/prill-iStock-682222256-fattyliver101-web.jpg\",\"contentUrl\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/prill-iStock-682222256-fattyliver101-web.jpg\",\"width\":1600,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/2026\\\/11\\\/fattyliver101\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Fatty Liver (or MASLD) 101\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/#website\",\"url\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/\",\"name\":\"HepSA Community News\",\"description\":\"Hepatitis news and views from South Australia\",\"publisher\":{\"@id\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-AU\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/#organization\",\"name\":\"Hepatitis SA\",\"url\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-AU\",\"@id\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/HepSA_rgb.png\",\"contentUrl\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/HepSA_rgb.png\",\"width\":2025,\"height\":955,\"caption\":\"Hepatitis SA\"},\"image\":{\"@id\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/HepatitisSA\",\"https:\\\/\\\/x.com\\\/hep_sa\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/#\\\/schema\\\/person\\\/ad926e1f11c1abf6ece6961500fe2a4e\",\"name\":\"Rose Magdalene\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-AU\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c167a78e6466fff8d1128b08c88ec8526e84590907ab02a6825e3a55656644a0?s=96&d=mm&r=g758e90e5ae5477158d7eadcd871286f3\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c167a78e6466fff8d1128b08c88ec8526e84590907ab02a6825e3a55656644a0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c167a78e6466fff8d1128b08c88ec8526e84590907ab02a6825e3a55656644a0?s=96&d=mm&r=g\",\"caption\":\"Rose Magdalene\"},\"url\":\"https:\\\/\\\/hepatitissa.asn.au\\\/communitynews\\\/author\\\/rose-magdalene\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fatty Liver (or MASLD) 101 | HepSA Community News","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hepatitissa.asn.au\/communitynews\/2026\/11\/fattyliver101\/","og_locale":"en_US","og_type":"article","og_title":"Fatty Liver (or MASLD) 101 | HepSA Community News","og_description":"Fatty&nbsp;liver disease, the lay term for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), is a common condition that affects one in three people in Australia. It was previously referred to as&hellip;","og_url":"https:\/\/hepatitissa.asn.au\/communitynews\/2026\/11\/fattyliver101\/","og_site_name":"HepSA Community News","article_publisher":"https:\/\/www.facebook.com\/HepatitisSA","article_published_time":"2026-11-09T03:30:52+00:00","article_modified_time":"2026-11-10T04:46:51+00:00","og_image":[{"width":1600,"height":900,"url":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2026\/11\/prill-iStock-682222256-fattyliver101-web.jpg","type":"image\/jpeg"}],"author":"Rose Magdalene","twitter_card":"summary_large_image","twitter_creator":"@hep_sa","twitter_site":"@hep_sa","twitter_misc":{"Written by":"Rose Magdalene","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/hepatitissa.asn.au\/communitynews\/2026\/11\/fattyliver101\/#article","isPartOf":{"@id":"https:\/\/hepatitissa.asn.au\/communitynews\/2026\/11\/fattyliver101\/"},"author":{"name":"Rose Magdalene","@id":"https:\/\/hepatitissa.asn.au\/communitynews\/#\/schema\/person\/ad926e1f11c1abf6ece6961500fe2a4e"},"headline":"Fatty Liver (or MASLD) 101","datePublished":"2026-11-09T03:30:52+00:00","dateModified":"2026-11-10T04:46:51+00:00","mainEntityOfPage":{"@id":"https:\/\/hepatitissa.asn.au\/communitynews\/2026\/11\/fattyliver101\/"},"wordCount":299,"commentCount":0,"publisher":{"@id":"https:\/\/hepatitissa.asn.au\/communitynews\/#organization"},"image":{"@id":"https:\/\/hepatitissa.asn.au\/communitynews\/2026\/11\/fattyliver101\/#primaryimage"},"thumbnailUrl":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2026\/11\/prill-iStock-682222256-fattyliver101-web.jpg","keywords":["MASLD","fatty liver","NAFLD"],"articleSection":["Resources","Living with Hepatitis"],"inLanguage":"en-AU","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/hepatitissa.asn.au\/communitynews\/2026\/11\/fattyliver101\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/hepatitissa.asn.au\/communitynews\/2026\/11\/fattyliver101\/","url":"https:\/\/hepatitissa.asn.au\/communitynews\/2026\/11\/fattyliver101\/","name":"Fatty Liver (or MASLD) 101 | HepSA Community News","isPartOf":{"@id":"https:\/\/hepatitissa.asn.au\/communitynews\/#website"},"primaryImageOfPage":{"@id":"https:\/\/hepatitissa.asn.au\/communitynews\/2026\/11\/fattyliver101\/#primaryimage"},"image":{"@id":"https:\/\/hepatitissa.asn.au\/communitynews\/2026\/11\/fattyliver101\/#primaryimage"},"thumbnailUrl":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2026\/11\/prill-iStock-682222256-fattyliver101-web.jpg","datePublished":"2026-11-09T03:30:52+00:00","dateModified":"2026-11-10T04:46:51+00:00","breadcrumb":{"@id":"https:\/\/hepatitissa.asn.au\/communitynews\/2026\/11\/fattyliver101\/#breadcrumb"},"inLanguage":"en-AU","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hepatitissa.asn.au\/communitynews\/2026\/11\/fattyliver101\/"]}]},{"@type":"ImageObject","inLanguage":"en-AU","@id":"https:\/\/hepatitissa.asn.au\/communitynews\/2026\/11\/fattyliver101\/#primaryimage","url":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2026\/11\/prill-iStock-682222256-fattyliver101-web.jpg","contentUrl":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2026\/11\/prill-iStock-682222256-fattyliver101-web.jpg","width":1600,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/hepatitissa.asn.au\/communitynews\/2026\/11\/fattyliver101\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hepatitissa.asn.au\/communitynews\/"},{"@type":"ListItem","position":2,"name":"Fatty Liver (or MASLD) 101"}]},{"@type":"WebSite","@id":"https:\/\/hepatitissa.asn.au\/communitynews\/#website","url":"https:\/\/hepatitissa.asn.au\/communitynews\/","name":"HepSA Community News","description":"Hepatitis news and views from South Australia","publisher":{"@id":"https:\/\/hepatitissa.asn.au\/communitynews\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hepatitissa.asn.au\/communitynews\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-AU"},{"@type":"Organization","@id":"https:\/\/hepatitissa.asn.au\/communitynews\/#organization","name":"Hepatitis SA","url":"https:\/\/hepatitissa.asn.au\/communitynews\/","logo":{"@type":"ImageObject","inLanguage":"en-AU","@id":"https:\/\/hepatitissa.asn.au\/communitynews\/#\/schema\/logo\/image\/","url":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2024\/03\/HepSA_rgb.png","contentUrl":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2024\/03\/HepSA_rgb.png","width":2025,"height":955,"caption":"Hepatitis SA"},"image":{"@id":"https:\/\/hepatitissa.asn.au\/communitynews\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/HepatitisSA","https:\/\/x.com\/hep_sa"]},{"@type":"Person","@id":"https:\/\/hepatitissa.asn.au\/communitynews\/#\/schema\/person\/ad926e1f11c1abf6ece6961500fe2a4e","name":"Rose Magdalene","image":{"@type":"ImageObject","inLanguage":"en-AU","@id":"https:\/\/secure.gravatar.com\/avatar\/c167a78e6466fff8d1128b08c88ec8526e84590907ab02a6825e3a55656644a0?s=96&d=mm&r=g758e90e5ae5477158d7eadcd871286f3","url":"https:\/\/secure.gravatar.com\/avatar\/c167a78e6466fff8d1128b08c88ec8526e84590907ab02a6825e3a55656644a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c167a78e6466fff8d1128b08c88ec8526e84590907ab02a6825e3a55656644a0?s=96&d=mm&r=g","caption":"Rose Magdalene"},"url":"https:\/\/hepatitissa.asn.au\/communitynews\/author\/rose-magdalene\/"}]}},"authors":[{"term_id":128,"user_id":5,"is_guest":0,"slug":"rose-magdalene","display_name":"Rose Magdalene","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/c167a78e6466fff8d1128b08c88ec8526e84590907ab02a6825e3a55656644a0?s=96&d=mm&r=g","avatar_alt":"","avatar_decorative":"","author_category":"","first_name":"Rose","last_name":"Magdalene","user_url":"","job_title":"","description":""}],"_links":{"self":[{"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/posts\/8499","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/comments?post=8499"}],"version-history":[{"count":7,"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/posts\/8499\/revisions"}],"predecessor-version":[{"id":8517,"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/posts\/8499\/revisions\/8517"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/media\/8505"}],"wp:attachment":[{"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/media?parent=8499"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/categories?post=8499"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/tags?post=8499"},{"taxonomy":"issue","embeddable":true,"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/issue?post=8499"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/ppma_author?post=8499"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}